Maynard Um
-
-
-
-
-
-
-
Survey finds Alzheimer's agitation often goes unrecognized until daily disruption
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) Misses Q2 EPS by 14c
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $246 at Baird
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) Misses Q1 EPS by 43c
-
-
-
-
-
-
-
Piper Sandler on Axsome Therapeutics (AXSM): 'A High-Risk, High-Reward Opportunity'
-
-
-
-
-
-
-
RBC Capital Defending on Axsome Therapeutics (AXSM)
-
468,741 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


